Skip to main content
. Author manuscript; available in PMC: 2017 Oct 1.
Published in final edited form as: Circ Heart Fail. 2016 Oct;9(10):e002962. doi: 10.1161/CIRCHEARTFAILURE.115.002962

Figure 3. Hazard Ratio of Outcome Based Upon Predictors of ACM, CVM, HF Hospitalization, and ACM or HF Hospitalization.

Figure 3

Figure 3

Figure 3

Figure 3

3a indicates ACM; 3b, CVM; 3c, HFH, HF Hospitalization; and 3d, ACM or HFH. The predictors included the presence versus absence of disease in binary fashion unless noted otherwise: age (continuous: years (yr)/10); atrial fibrillation; CAD, coronary artery disease; CHF, congestive heart failure duration (continuous variable in months (mon)/25); creatinine (continuous: mg/dL); diabetes; LVEF, baseline left ventricular ejection fraction <20% versus ≥ 20%; fluid overload; heart rate (continuous: beats per minute (bpm)/10); LVEF Responder, change in LVEF from baseline to month 12 ≥5 units; NYHA, New York Heart Association class 3 versus 4; race, African-American versus Non-African-American; SBP, systolic blood pressure (continuous: millimeters of mercury (mmHg)/10); Sex, males versus females; Site type, Veteran Affairs Medical Center vs. non-veteran affairs medical center; Sodium (continuous: milliequivalents/liter (MEq/L)/5); and Treatment, treatment group bucindolol vs. placebo. Chi2p indicates the chi squared p-value.